N/A N=251 Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption
Placenta, Retained · Postpartum Hemorrhage
Primary: Placental Retention Rate — 26; 8; 24 participants — p=0.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=69 Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss
Lactation Suppressed
Primary: Number of Participants Reporting Breast Pain — 16; 30 Participants
Phase 2 N=73 Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss
Lactation Suppressed
Primary: Number of Participants Reporting Breast Pain — 10; 32 Participants
N/A N=23 Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
Iron-deficiency · Pregnancy Anemia · Obesity
Primary: Recruitment Feasibility — 10 percentage eligible and enrolled
Phase 4 N=30 Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
Abortion, Second Trimester · PPROM · Rupture, Spontaneous
Primary: Delivery Within 12 Hours — 5; 5 Participants
N/A N=80 Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services
Legally Induced Abortion Without Mention of Complication
Primary: Procedure Time — 13; 12; 18.5 minutes
Phase 3 N=50 Paracervical Block in First Trimester Surgical Abortions
Pain · Surgical Abortion
Primary: Level of Pain During Specific Time Intervals Throughout D&C Procedure. — 52.2; 51.7; 33.6; 32.7 mm — p=0.94
N/A N=70 Transcutaneous Electrical Nerve Stimulation for Pain Control During First-trimester Abortion
Abortion in First Trimester · Pain
Primary: Pain During Cervical Dilation — 44; 50 millimeters on VAS
N/A N=128 Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O)
Obesity
Primary: Completion Rate for First Trimester Scans — 66 percent
N/A N=2 Safety of 4CMenB Exposure During Pregnancy
Infections, Meningococcal
Primary: Major Congenital Malformation (MCM)
N/A N=120 Monitoring Movement and Health Study
Pregnancy Related · Obesity · Hypertension
Primary: Number of Participants Classified as Having High Sedentary Behavior (by Trajectory) — 45 Participants
Phase 3 N=750 Pregnancy in Polycystic Ovary Syndrome II
Pregnancy · Polycystic Ovary Syndrome
Primary: Live Birth — 72; 103 Participants — p=0.007
N/A N=120 Personalized Integrated Chronotherapy for Perinatal Depression
Depression · Postpartum Depression · Prenatal Disorder
Primary: Change in Depressive Symptoms — 1.6; 2.2 units on a scale
N/A N=104 Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Termination of Pregnancy Analgesia
Medical; Abortion, Fetus
Primary: Incidence of Motor Block — 24; 3 participants — p=< 0.001
N/A N=78 Completion of OST - a Prospective Study
Opioid Dependence
Primary: Completion of OST — 9 participants